IL323739A - טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמיד - Google Patents
טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמידInfo
- Publication number
- IL323739A IL323739A IL323739A IL32373925A IL323739A IL 323739 A IL323739 A IL 323739A IL 323739 A IL323739 A IL 323739A IL 32373925 A IL32373925 A IL 32373925A IL 323739 A IL323739 A IL 323739A
- Authority
- IL
- Israel
- Prior art keywords
- weight
- kernel
- total weight
- tablet
- filler
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23169355 | 2023-04-24 | ||
| PCT/EP2024/060856 WO2024223450A1 (en) | 2023-04-24 | 2024-04-22 | Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL323739A true IL323739A (he) | 2025-11-01 |
Family
ID=86184883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL323739A IL323739A (he) | 2023-04-24 | 2025-09-30 | טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמיד |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4701621A1 (he) |
| JP (1) | JP2026513673A (he) |
| KR (1) | KR20250169340A (he) |
| CN (1) | CN121001709A (he) |
| AU (1) | AU2024262426A1 (he) |
| IL (1) | IL323739A (he) |
| MX (1) | MX2025012538A (he) |
| TW (1) | TW202506123A (he) |
| WO (1) | WO2024223450A1 (he) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA48594B1 (fr) | 2016-12-08 | 2022-05-31 | Hoffmann La Roche | Nouveaux dérivés d'éther d'isoxazolyle en tant que pam alpha5 gaba a |
-
2024
- 2024-04-22 CN CN202480027196.5A patent/CN121001709A/zh active Pending
- 2024-04-22 KR KR1020257035456A patent/KR20250169340A/ko active Pending
- 2024-04-22 WO PCT/EP2024/060856 patent/WO2024223450A1/en not_active Ceased
- 2024-04-22 EP EP24719202.4A patent/EP4701621A1/en active Pending
- 2024-04-22 AU AU2024262426A patent/AU2024262426A1/en active Pending
- 2024-04-22 JP JP2025562021A patent/JP2026513673A/ja active Pending
- 2024-04-23 TW TW113115054A patent/TW202506123A/zh unknown
-
2025
- 2025-09-30 IL IL323739A patent/IL323739A/he unknown
- 2025-10-21 MX MX2025012538A patent/MX2025012538A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024262426A1 (en) | 2025-09-18 |
| TW202506123A (zh) | 2025-02-16 |
| WO2024223450A1 (en) | 2024-10-31 |
| JP2026513673A (ja) | 2026-04-30 |
| EP4701621A1 (en) | 2026-03-04 |
| CN121001709A (zh) | 2025-11-21 |
| MX2025012538A (es) | 2025-11-03 |
| KR20250169340A (ko) | 2025-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5296456B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
| JP2008503475A (ja) | メマンチンの放出が改変された製剤 | |
| EP2251005A1 (en) | Orally disintegrating tablets | |
| JP2012517458A (ja) | リナグリプチン及び必要に応じてsglt2阻害薬を含む医薬組成物、並びにその使用 | |
| JP5656258B2 (ja) | ガランタミンを含有する口腔内崩壊錠剤 | |
| US20090099203A1 (en) | Composition 064 | |
| JP6919119B2 (ja) | 3位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 | |
| JP2010270110A (ja) | ネオテームを含有する経口製剤 | |
| WO2016051782A1 (ja) | 苦味を有する薬剤の苦味をマスキングした経口投与製剤 | |
| HK1245646A1 (zh) | 口服给药用医药组合物 | |
| JP6803250B2 (ja) | エレトリプタン臭化水素酸塩含有口腔内崩壊錠 | |
| US20210244730A1 (en) | Pharmaceutical composition containing an antitumor agent | |
| US20140343076A1 (en) | Pharmaceutical compositions of lurasidone | |
| WO2026103205A1 (zh) | 一种匹莫范色林或其盐的口崩片及其制备方法 | |
| US20230201234A1 (en) | Fast dispersible pharmaceutical composition comprising capecitabine | |
| EP3930691B1 (en) | Pharmaceutical composition containing acetominophen and ibuprofen | |
| WO2007144902A1 (en) | Chewable bilayer tablet formulation | |
| WO2024223450A1 (en) | Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide | |
| JP5978335B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
| TW202135802A (zh) | 包含吡咯羧醯胺之口腔崩散錠 | |
| WO2004096214A1 (en) | A rapidly disintegrable composition for masking the bitter taste of ondansetron or a pharmaceutically acceptable salt thereof | |
| JP2017141299A (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
| RU2633477C2 (ru) | Таблетка, содержащая гидрат метансульфоната 1-циклопропил-8-(дифторметокси)-7-[(1r)-1-метил-2, 3-дигидро-1н-изоиндол-5-ил]-4-оксо-1, 4-дигидрохинолин-3-карбоновой кислоты | |
| US20060034911A1 (en) | New oral immediated release dosage form | |
| HK40128711A (zh) | 包含6-((5-甲基-3-(6-甲基吡啶-3-基)异恶唑-4-基)甲氧基)-n-(四氢吡喃-4-基)哒嗪-3-甲酰胺的片剂 |